Premenstrual dysphoric disorder: A review for the treating practitioner

Article Type

Article

Changed

Fri, 10/05/2018 - 06:55

Display Headline

Premenstrual dysphoric disorder: A review for the treating practitioner

Author(s)

Gurjit Kaur, DO

Lilian Gonsalves, MD

Holly L. Thacker, MD, FACP, NCMP, CCD

Article PDF

content_71_303.pdf

Author and Disclosure Information

Gurjit Kaur, DO
Department of General Internal Medicine, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Lilian Gonsalves, MD
Department of Psychiatry and Psychology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Holly L. Thacker, MD
Department of General Internal Medicine, Department of Obstetrics and Gynecology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Address: Gurjit Kaur, DO, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kaurg@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Adminstration for the use under discussion.

Issue

Cleveland Clinic Journal of Medicine - 71(4)

Publications

Cleveland Clinic Journal of Medicine

Topics

Women's Health

Mental Health

Drug Therapy

Page Number

303-305, 312-313, 317-318, 320-321

Sections

Reviews

Author(s)

Gurjit Kaur, DO

Lilian Gonsalves, MD

Holly L. Thacker, MD, FACP, NCMP, CCD

Author(s)

Gurjit Kaur, DO

Lilian Gonsalves, MD

Holly L. Thacker, MD, FACP, NCMP, CCD

Author and Disclosure Information

Gurjit Kaur, DO
Department of General Internal Medicine, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Lilian Gonsalves, MD
Department of Psychiatry and Psychology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Holly L. Thacker, MD
Department of General Internal Medicine, Department of Obstetrics and Gynecology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Address: Gurjit Kaur, DO, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kaurg@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Adminstration for the use under discussion.

Author and Disclosure Information

Gurjit Kaur, DO
Department of General Internal Medicine, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Lilian Gonsalves, MD
Department of Psychiatry and Psychology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Holly L. Thacker, MD
Department of General Internal Medicine, Department of Obstetrics and Gynecology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Address: Gurjit Kaur, DO, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kaurg@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Adminstration for the use under discussion.

Article PDF

content_71_303.pdf

Article PDF

content_71_303.pdf

Issue

Cleveland Clinic Journal of Medicine - 71(4)

Issue

Cleveland Clinic Journal of Medicine - 71(4)

Page Number

303-305, 312-313, 317-318, 320-321

Page Number